DSMLX
Price
$60.81
Change
-$0.03 (-0.05%)
Updated
Nov 13 closing price
GFACX
Price
$70.91
Change
-$0.13 (-0.18%)
Updated
Nov 13 closing price
Ad is loading...

DSMLX vs GFACX

Header iconDSMLX vs GFACX Comparison
Open Charts DSMLX vs GFACXBanner chart's image
Touchstone Large Company Growth Instl
Price$60.81
Change-$0.03 (-0.05%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer C
Price$70.91
Change-$0.13 (-0.18%)
VolumeN/A
CapitalizationN/A
DSMLX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DSMLX vs. GFACX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSMLX is a StrongBuy and GFACX is a StrongBuy.

FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 306B vs. DSMLX (158M). DSMLX (0.00) and GFACX (0.00) have matching dividends . DSMLX was incepted earlier than GFACX: DSMLX (15 years) vs GFACX (24 years). DSMLX is a more actively managed with annual turnover of: 44.00 vs. GFACX (31.00). GFACX has a lower initial minimum investment than DSMLX: GFACX (250) vs DSMLX (500000). DSMLX annual gain was more profitable for investors over the last year : 37.96 vs. GFACX (32.39). GFACX return over 5 years is better than : 50.38 vs. DSMLX (37.40).
DSMLXGFACXDSMLX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years24 years-
Gain YTD32.26129.164111%
Front LoadN/AN/A-
Min. Initial Investment500000250200,000%
Min. Initial Investment IRAN/AN/A-
Net Assets158M306B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year37.9632.39117%
Returns for 3 years-2.03-5.2838%
Returns for 5 years37.4050.3874%
Returns for 10 years90.9659.14154%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PR15.190.08
+0.53%
Permian Resources Corp
CPK126.03-0.41
-0.32%
Chesapeake Utilities
MCRB0.66-0.03
-4.02%
Seres Therapeutics
MLAB112.57-6.37
-5.36%
Mesa Laboratories
HEPA0.62-0.04
-6.44%
Hepion Pharmaceuticals